Skip to main content
. 2020 Jan 11;22:100562. doi: 10.1016/j.ymgmr.2019.100562

Table 1.

Variants detected in newborn screening for Fabry disease.

Variant No. Nucleotide change Amino acid
change
Location Databases
PolyPhen-2 (Score) Amenability** Classification
ClinVar Fabry-database.org*
1 c.2 T > A p.M1K Exon 1 NR Dobrovolny (2008) Benign (0.080) Pathogenic (classic)
2 c.124A > G p.M42 V Exon 1 Pathogenic Park (2009) Probably damaging +
3 c.128G > A p.G43D Exon 1 NR Sakuraba (1990) Probably damaging
7 c.431G > A p.G144D Exon 3 NR Li (2014) Probably damaging +
11 c.595G > A p.V199 M Exon 4 Uncertain significance Shabbeer (2002) Probably damaging +
23 c.1072_1074delGAG p.E358del Exon 7 NR NR
25 c.1208 T > C p.L403S Exon 7 NR Shimotori (2008) Probably damaging +
4 c.290C > T p.A97V Exon 2 pathogenic Eng (1997) Possibly damaging (0.882) + Pathogenic (non-classic)
5 c.335G > A p.R112H Exon 2 pathogenic Shimotori (2008) Probably damaging +
8 c.436C > T p.P146S Exon 3 pathogenic Mild, late-onset Probably damaging +
14 c.628C > T p.P210S Exon 4 NR Eng (1994) Possibly damaging (0.758) +
15 c.639 + 919G > A Intron 4 pathogenic NR ?
16 c.644A > G p.N215S Exon 5 pathogenic Ebrahim (2012) Benign (0.048) +
18 c.687 T > G p.F229 L Exon 5 NR Kawano (2007) Possibly damaging (0.950) +
21 c.888G > A p.M296I Exon 6 pathogenic Saito (2013) Benign (0.309) +
6 c.428C > T p.A143V Exon 3 NR NR Probably damaging NA VOUS
9 c.493G > A p.D165N Exon 3 NR NR Probably damaging NA
12 c.605G > T p.C202F Exon 4 NR NR Probably damaging NA
17 c.685 T > G p.F229 V Exon 5 NR NR Probably damaging NA
19 c.714 T > A p.S238R Exon 5 NR NR Probably damaging
26 c.1231G > A p.G411S Exon 7 NR NR Probably damaging NA
10 c.538 T > G p.L180 V Exon 3 NR NR Possibly damaging (0.470) NA
24 c.1171A > G p.K391E Exon 7 NR NR Benign (0.266) +
22 c.1067G > A p.R356Q Exon 7 Conflicting interpretations of pathogenicity Hwu (2009) Benign (0.190) +
20 c.725 T > C p.I242T Exon 5 NR NR Benign (0.079) +
13 c.625 T > C p.W209R Exon 4 NR NR Benign (0.000) NA

*last updated February 15, 2019 (ver.3.2.2), **Summary of product characteristics of Galafold®, Table 2, Table 3. +: amenable, −: not amenable,?: unknown, NA: not available.

NR: not registered, VOUS: variants of uncertain significance: Novel variatns.